KalVista Pharmaceuticals Acquired by Chiesi Farmaceutici | Healthcare M&A Deal

Chiesi Farmaceutici has agreed to acquire KalVista Pharmaceuticals, a pharmacy business in Massachusetts, for $27.00 per share in a going private acquisition. KalVista Pharmaceuticals develops specialty medicines for patients, supporting Chiesi Farmaceutici acquisitions in the healthcare sector and expanding its pharmacy pipeline in MA. Chiesi Farmaceutici is pursuing a strategic acquisition to strengthen its presence in healthcare M&A and MA acquisitions tied to specialty therapeutics. The deal is structured as a tender offer through Skyline Merger Sub, a wholly owned subsidiary of Chiesi, with an announced over-$100M transaction size and cash consideration net to sellers.